Demopulos Peter A MD 4
4 · OMEROS CORP · Filed Jun 22, 2026
Research Summary
AI-generated summary of this filing
Omeros (OMER) Director Peter Demopulos Receives 15,000-Share Option
What Happened Dr. Peter A. Demopulos, a non-employee director of Omeros Corporation (OMER), was granted an option covering 15,000 shares on June 18, 2026. The Form 4 reports this derivative award at an acquisition price of $0.00 (reflecting an option grant rather than a cash purchase). The filing does not state the option strike price or immediate monetary value.
Key Details
- Transaction date: 2026-06-18 (reported on Form 4 filed 2026-06-22).
- Transaction type/code: A — Award/Grant (derivative security).
- Shares/options granted: option to purchase 15,000 shares; acquisition value shown as $0.00.
- Vesting: The option will fully vest and become exercisable the day before the 2027 annual meeting, provided Demopulos remains a director (per footnote).
- Policy: Grant was made under Omeros’ non-employee director compensation policy, which automatically awards this option to qualifying directors after the annual meeting.
- Shares owned after transaction: the filing does not disclose the reporting person's total post-transaction beneficial ownership.
- Timeliness: Form 4 was filed within the normal two-business-day window (transaction 6/18, filed 6/22).
Context This is a routine director compensation award, not an open-market buy or sale. Such grants are common for non-employee directors and do not by themselves indicate an immediate buy/sell signal for investors. The economic impact to Demopulos (and to shareholders) will depend on the option's strike price, future vesting, and whether/when the option is exercised or shares are sold.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1][F2]2026-06-18+15,000→ 15,000 totalExercise: $10.28Exp: 2036-06-17→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026.
- [F2]This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.